Diabetic Cystopathy

  • Marelyn Medina
  • John R. Tomasula
  • Linda S. Cohen
  • Gobind B. Laungani
  • Khalid M. H. Butt
  • Eli A. Friedman
Part of the Topics in Renal Medicine book series (TIRM, volume 6)


Neuropathy of the bladder in diabetes predisposes patients to urinary tract infection and functional obstruction of urine flow. Azotemia and uremia may result earlier in patients with diabetic nephropathy who also have unrecognized or inadequately treated diabetic cystopathy. Diabetic recipients of renal allografts may manifest fluctuations in serum creatinine and blood urea nitrogen concentration because of intermittent inability to empty the bladder due to cystopathy. Differentiation of the effects of cystopathy from nephropathy in a diabetic requires awareness of clinical syndromes resulting from each entity. Elsewhere in this text, diabetic nephropathy is discussed. The present chapter reviews the pathogenesis, presentation, and management of diabetic cystopathy.


Urinary Tract Infection Urethral Catheter Neurogenic Bladder Intermittent Catheterization Clean Intermittent Catheterization 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Frimodt-Moller C: Diabetic cystopathy: epidemiology and related disorders. Ann Intern Med 92: 318–321, 1980.PubMedGoogle Scholar
  2. 2.
    Martin MM: Diabetic neuropathy: a clinical study of 150 cases. Brain 76: 594–624, 1953.PubMedCrossRefGoogle Scholar
  3. 3.
    Rundles RW: Diabetic neuropathy: general review with report of 125 cases. Medicine 24: 111–160, 1945.CrossRefGoogle Scholar
  4. 4.
    Faerman I, Malek M, Jadzinsky M: Asymptomatic neurogenic bladder in juvenile diabetics. Diabetologia 7: 168–172, 1971.PubMedCrossRefGoogle Scholar
  5. 5.
    Frimodt-Moller, C.: Diabetic cystopathy. L A clinical study of the frequency of bladder dysfunction in diabetes. Dan Med Bull 23: 267–278, 1976.Google Scholar
  6. 6.
    Gibberd FB: The neurogenic bladder. Clin Obstet Gynecol 8: 149–160, 1981.Google Scholar
  7. 7.
    Rubinow ‘DR, Nelson Jc: Tricyclic exacerbation of undiagnosed diabetic uropathy. J Clin Psychiatry 43: 210–212, 1982.Google Scholar
  8. 8.
    Ellenberg M: Development of urinary bladder dysfunction in diabetes mellitus. Ann Intern Med 92: 321–323, 1980.PubMedGoogle Scholar
  9. 9.
    Smith DR: General urology, 9th edn. Los Altos CA: Lange, 1978, p 31.Google Scholar
  10. 10.
    Hinman F: Nonneurogenic neurogenic bladder (the Hinman syndrome): 15 years later. J Urol 136: 769–777, 1986.PubMedGoogle Scholar
  11. 11.
    Frimodt-Moller C: Diabetic cystopathy III: urinary bladder dysfunction in relation to bacteriuria. Dan Med Bull 23: 287–290, 1976.Google Scholar
  12. 12.
    Parrish JA: Urinary infection in diabetic outpatients. Lancet 2: 414–415, 1965.PubMedCrossRefGoogle Scholar
  13. 13.
    Ellenberg M: Diabetic neurogenic vesical dysfunction. Arch Intern Med 117: 348–354, 1966.CrossRefGoogle Scholar
  14. 14.
    Kahan M, Goldberg PD, Mandel EE: Neurogenic vesical dysfunction and diabetes mellitus. NY State J Med 2: 2448–2455, 1970.Google Scholar
  15. 15.
    Motzkin D: The significance of deficient bladder sensation. J Urol 100: 445–450, 1968.PubMedGoogle Scholar
  16. 16.
    Stamey TA: Pathogenesis and treatment of urinary tract infection. Baltimore: Williams and Wilkins, 1980, p 6.Google Scholar
  17. 17.
    Turck M, Gaffe B, Petersdorf RG: The urethral catheter and urinary tract infection. Urology 88: 834–837, 1962.Google Scholar
  18. 18.
    Kass EH: Asymptomatic infections of the urinary tract. Trans Assoc Am Phys 69: 56–64, 1956.PubMedGoogle Scholar
  19. 19.
    Brumfitt W, Davies BI, Rosser EI: Urethral catheter as a cause of urinary tract infection in pregnancy and puerperium. Lancet 2: 1059–1062, 1961.PubMedCrossRefGoogle Scholar
  20. 20.
    Kaye M, de Vries J, MacFarlane KT: The initiation of urinary tract infection following a single bladder catheterization. Can Med Assoc J 86: 9–14, 1962.PubMedGoogle Scholar
  21. 21.
    Marple CD: The frequency and character of a urinary tract infection in an unselected group of women. Ann Intern Med 14: 2220–2228, 1941.Google Scholar
  22. 22.
    Thiel G, Spuhler D: Urinary tract infection by catheter and the so-called infectious (episomal) resistence. Schweiz Med Wochenschr 95: 1155–1157, 1965.PubMedGoogle Scholar
  23. 23.
    Witten DM, Myers GM, Utz DC (eds): Emmett’s clinical urography, 4th edn. Philadelphia: WB Saunders, 1977, p 5.Google Scholar
  24. 24.
    Andersen JT, Bradley WE: Abnormalities of bladder innervation in diabetes mellitus. Urology 7: 442–448, 1976.PubMedCrossRefGoogle Scholar
  25. 25.
    Wein AJ: Nonsurgical treatment of lower urinary tract dysfunction female urology. Raz S (ed), Female Urology, Philadelphia: WB Saunders, 1983.Google Scholar
  26. 26.
    Harrison JH, Gitters RF, Perlmutter AD, Stamey TA, Walsh PC (eds): Campbell’s urology, 4th edn. Philadelphia: WB Saunders, 1978, p 366.Google Scholar
  27. 27.
    Witten DM, Myers GH, Utz DC (eds): Emmett’s clinical urography, 4th edn. Philadelphia: WB Saunders, 1977, p 45.Google Scholar
  28. 28.
    Bors E: Neurogenic bladder. Urol Sury 7: 177–250, 1957.Google Scholar
  29. 29.
    Wein AJ, Raezer DM, Benson GS: Management of neurogenic bladder dysfunction in the adult. Urology 8: 432–443, 1976.PubMedCrossRefGoogle Scholar
  30. 30.
    Frimodt-Moller C, Mortensen S: Treatment of diabetic cystopathy. Ann Intern Med 92: 327–328, 1980.PubMedGoogle Scholar
  31. 31.
    Koelle GB: Parasympathomimetic agents. In: Goodman LS, Gilman AG (eds) Pharmacological basis of therapeutics. New York: Macmillan, 1975, p 469.Google Scholar
  32. 32.
    Wein AJ: Pharmacologic treatment of lower urinary tract dysfunction in the female patient. Urol Clin North Am 12: 259–269, 1985.PubMedGoogle Scholar
  33. 33.
    Lapides J: Neurogenic bladder: principles of treatment. Urol Clin North Am 1: 81–97, 1974.PubMedGoogle Scholar
  34. 34.
    Sonda L, Gershon C, Diokro A, Lapides J: Further observations on the cystometric and uroflowmetric effects of bethanecol chloride on the human bladder. J Urol 122: 775–777, 1979.PubMedGoogle Scholar
  35. 35.
    Frimodt-Moller C: Diabetic cystopathy. Dan Med Bull 25: 49–60, 1978.PubMedGoogle Scholar
  36. 36.
    Desmond AD, Bultitude MI, Hills NH, Shuttleworth KED: Clinical experience with intravesical prostaglandin E2: a prospective study of 36 patients. Br J Urol 52: 357–366, 1980.PubMedCrossRefGoogle Scholar
  37. 37.
    Vaidyanathan S, Rao MS, Mapa MK, Bqpna BC, Chary Ksn, Swamy RP: Detrusor super-sensitivity to 15(5)15-methyl prostaglandin F2 alpha in chronic neurologic vesical dysfunction. Indian J Med Res 75: 839–845, 1982.PubMedGoogle Scholar
  38. 38.
    Lapides J, Diokno AC, Gould FR, Lowe BS: Clean, intermittent self-catheterization in the treatment of urinary tract disease. J Urol 107: 458–461, 1972.PubMedGoogle Scholar
  39. 39.
    Lapides J, Dionkno AC, Gould FR, Lowe BS: Further observations on self-catheterization. J Urol 116: 169–171, 1976.PubMedGoogle Scholar
  40. 40.
    Kunin CM: Detection, prevention and management of urinary tract infection, 3rd edn. Philadelphia: Lea and Febiger, 1979, p 66.Google Scholar
  41. 41.
    Broecker BH, Klein FA, Hackler RM: Cancer of the bladder in spinal cord injury patients. J Urol 125: 196–197, 1981.PubMedGoogle Scholar
  42. 42.
    Applebaum SM: Pharmacologic agents in micturitional disorders. Urology 16: 555–567, 1980.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1988

Authors and Affiliations

  • Marelyn Medina
  • John R. Tomasula
  • Linda S. Cohen
  • Gobind B. Laungani
  • Khalid M. H. Butt
  • Eli A. Friedman

There are no affiliations available

Personalised recommendations